Press Needle Acupuncture for Pain and Quality of Life in Lung Cancer Patients
ConditionLung Cancer Patients
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorIndonesia University
About this trial
The purpose of this clinical trial is to evaluate the effect of press needle acupuncture on pain management and quality of life improvement in patients with lung cancer.
The main question this study aims to answer is:
Does press needle acupuncture, when combined with standard therapy, provide better pain relief and quality of life improvement in lung cancer patients compared to standard therapy alone?
Researchers will compare press needle acupuncture to sham acupuncture to determine whether press needle acupuncture is more effective in reducing pain and improving quality of life.
Participants will:
Receive either press needle acupuncture or sham press needle acupuncture for 7 days
Visit the clinic once a week for examination and evaluation
Record improvements in pain intensity in a pain diary and assess quality of life using a quality of life questionnaire
Eligibility criteria
Qualifiers
Patients with a confirmed diagnosis of lung cancer through histopathology or radiology.
Lung cancer patients aged over 18 years.
Stage III-IV lung cancer patients receiving therapy at Dr. Cipto Mangunkusumo National General Hospital (RSUPN) and Tangerang District General Hospital (RSUD Kabupaten Tangerang).
Patients with a VAS score >10 mm for baseline pain and >40 mm during breakthrough pain.
Disqualifiers
Lung cancer patients with deteriorating general condition.
Presence of wounds or infections at the press needle insertion site.
History of allergy to stainless steel materials.
Patients with blood clotting disorders: platelet count <50,000/μL, ANC <1000/mm³, or patients undergoing anticoagulant therapy with INR >2.142.
Trial design
Treatments tested in this trial
- Press Needle Acupuncture and standart therapy
Treatment groups
32 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov